112 results on '"Spaander, M. C."'
Search Results
2. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
3. Endoscopic screening for second primary tumors in the upper gastrointestinal tract in Western patients with head and neck cancer
4. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands
5. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma
6. Does Routine Endoscopy or Contrast Swallow Study After Esophagectomy and Gastric Tube Reconstruction Change Patient Management?
7. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
8. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis
9. Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
10. Impact of surveillance for Barrettʼs oesophagus on tumour stage and survival of patients with neoplastic progression
11. Surveillance in patients with long-segment Barrettʼs oesophagus: a cost-effectiveness analysis
12. Langetermijngevolgen van slokdarmatresie: Slokdarm- en longafwijkingen op volwassen leeftijd
13. Esophageal Stents in Malignant and Benign Disorders
14. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding
15. Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer.
16. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
17. Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
18. Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis
19. P84 LOCALIZATION OF UNDETECTED RESIDUAL TUMOR AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
20. O112 SURVEILLANCE USING FDG-UPTAKE IN THE PRIMARY TUMOUR ON PET/CT IN PATIENTS WITH OESOPHAGEAL CANCER AND A CLINICALLY COMPLETE RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY
21. Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe.
22. DOZ047.31: Screening and surveillance in adults after esophageal atresia repair: yield of follow-up endoscopies
23. DOZ047.60: Evaluation of gastroesophageal reflux in children born with esophageal atresia using pH and impedance monitoring
24. PS02.064: ACCURACY OF F-18-FDG-PET/CT IN MONITORING TUMOUR RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH OESOPHAGEAL CANCER
25. RA07.06: BASELINE FDG-PET/CT PARAMETERS AS PREDICTOR FOR RESIDUAL TUMOUR AFTER NEOADJUVANT CHEMORADIOTHERAPY IN OESOPHAGEAL CANCER PATIENTS
26. FA06.05: DETECTING RESIDUAL ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIATION BY ENDOSCOPIC BIOPSIES, EUS AND FDG-PET: A SYSTEMATIC REVIEW AND META-ANALYSIS
27. Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma
28. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers
29. Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer
30. Does Routine Endoscopy or Contrast Swallow Study After Esophagectomy and Gastric Tube Reconstruction Change Patient Management?
31. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
32. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.
33. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression
34. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study
35. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis
36. Short-Term Esophageal Stenting in the Management of Benign Perforations
37. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression.
38. DOZ047.31: Screening and surveillance in adults after esophageal atresia repair: yield of follow-up endoscopies.
39. Endoscopic removal of a broken self-expandable metal stent using the stent-in-stent technique.
40. Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening.
41. [Long-term consequences of esophageal atresia; esophageal and lung abnormalities in adulthood].
42. Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial.
43. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma?
44. Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.
45. Treatment of refractory post-esophagectomy anastomotic esophageal strictures using temporary fully covered esophageal metal stenting compared to repeated bougie dilation: results of a randomized controlled trial.
46. When to stop colonoscopy surveillance in the elderly?
47. Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.
48. Palliation of dysphagia.
49. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.
50. [Organ-sparing treatment in oesophagus cancer: feasible and safe?]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.